ArticleFrontiers in cardiovascular medicine2018

Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients.

Bibian M E Tullemans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.